title: [Acquired haemophilia: From registers' data to therapeutic recommendations].
authors.forename: H
authors.initials: H
authors.lastname: Lévesque
mesh_terms: D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D015942:Factor VIIa / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006467:Hemophilia A / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D017410:Practice Guidelines as Topic; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011644:Puerperal Disorders / Q000453:epidemiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D012042:Registries; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001779:Blood Coagulation Factors; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D000069283:Rituximab; D003520:Cyclophosphamide; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa; D011241:Prednisone